Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
07/2003
07/02/2003EP1322644A1 Farnesyl transferase inhibiting 6-heterocyclylmethyl quinolinone derivatives
07/02/2003EP1322643A1 Piperazin-2-one amides as inhibitors of factor xa
07/02/2003EP1322642A2 sHARMACEUTICALLY ACTIVE SULFONAMIDE DERIVATIVES BEARING BOTH LIPOPHILIC AND IONISABLE MOIETIES AS INHIBITORS OF PROTEIN JUNKINASES
07/02/2003EP1322641A1 Pharmaceutically active hydrophilic sulfonamide derivatives as inhibitors of protein junkinases
07/02/2003EP1322638A1 Antifungal and/or antiparasitic pharmaceutical composition and novel indole derivatives as active principle of such a composition
07/02/2003EP1322636A1 Farnesyl transferase inhibiting 6- (substituted phenyl)methyl]-quinoline and quinazoline derivatives
07/02/2003EP1322635A1 Farnesyl transferase inhibiting quinoline and quinazoline derivatives as farnesyl transferase inhibitors
07/02/2003EP1322634A1 N-phenyl-2-pyrimidine-amine derivatives
07/02/2003EP1322631A2 Methods of providing and using compounds ( retinoids ) having activity as inhibitors of cytochrome p450rai
07/02/2003EP1322630A2 Benzoylbenzofurane derivatives for treatment of cardiac arrhythmia
07/02/2003EP1322629A1 Tetrahydrofuran derivatives and their use as nk-1 antagonists
07/02/2003EP1322628A2 Substituted urea neuropeptide y y5 receptor antagonists
07/02/2003EP1322624A1 Arylalkane-sulfonamides having endothelin-antagonist activity
07/02/2003EP1322623A2 Hydroxy acid integrin antagonists
07/02/2003EP1322622A2 New n, n'-disubstituted benzimidazolone derivatives with affinity at the serotonin and dopamine receptors
07/02/2003EP1322621A1 New benzimidazolone derivatives displaying affinity at the serotonin and dopamine receptors
07/02/2003EP1322620A1 Benzimidazole and indole derivatives as crf receptor modulators
07/02/2003EP1322619A1 Isoquinolinone potassium channel inhibitors
07/02/2003EP1322618A1 Amino heterocyclic compounds (factor x a? inhibitors 14)
07/02/2003EP1322617A1 Compounds and methods for modulation of estrogen receptors
07/02/2003EP1322615A2 Fluorinated quinolones as antimitotic and antitumor agents
07/02/2003EP1322613A1 Spiroheterocyclic nitriles useful as reversible inhibitors of cysteine proteases
07/02/2003EP1322612A1 Substituted amino-aza-cycloalkanes useful against malaria
07/02/2003EP1322611A1 Chemical compounds
07/02/2003EP1322608A1 Delta1-pyrrolines used as pesticides
07/02/2003EP1322602A1 Substituted cinnamic acid guanidides, method for the production thereof, their use as a medicament, and to a medicament containing these compounds
07/02/2003EP1322599A2 Hiv integrase inhibitors
07/02/2003EP1322598A1 Nitroso diphenylamine derivatives
07/02/2003EP1322596A1 Zwitterionic tachykinin receptor antagonists
07/02/2003EP1322595A2 (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
07/02/2003EP1322593A1 O-substituted 6-methyl-tramadol derivatives
07/02/2003EP1322592A1 Substituted 1-aminobutan-3-ol derivatives
07/02/2003EP1322590A1 5-amino-1-pentene-3-ol substituted derivatives
07/02/2003EP1322351A1 Coated medical devices
07/02/2003EP1322350A1 E-ptfe foil impregnated with an encapsulated bioactive substance
07/02/2003EP1322336A1 Method of increasing testosterone and related steroid concentrations in women
07/02/2003EP1322334A2 Methods of inducing cancer cell death and tumor regression
07/02/2003EP1322333A2 Composition for combined use of aromatase inhibitors
07/02/2003EP1322331A2 Fatty acid synthase inhibitors
07/02/2003EP1322328A2 Vaccines for broad spectrum protection against diseases caused by neisseria meningitidis
07/02/2003EP1322325A1 Inhibiting hepatitis c virus processing and replication
07/02/2003EP1322319A1 Use of il-8 protein modulators in the treatment of viral infections
07/02/2003EP1322316A1 Diuretic or sulphonylurea for use in antiviral treatment
07/02/2003EP1322315A1 Formulations for reducing or eliminating toxicity of environmental hormones containing ursodeoxycholic acid
07/02/2003EP1322314A2 Treatment of diabetes mellitus by inhibition of mitochondrial calcium/sodium antiporter
07/02/2003EP1322313A2 Controlled release formulations for oral administration
07/02/2003EP1322312A1 Use of medicaments
07/02/2003EP1322311A1 Treatment of inflammation with a combination of a cyclooxygenase-2 inhibitor and an integrin alpha-v antagonist
07/02/2003EP1322310A1 Alpha v integrin receptor antagonists
07/02/2003EP1322309A2 High affinity small molecule c5a receptor modulators
07/02/2003EP1322308A2 Devices and methods for management of inflammation
07/02/2003EP1322307A1 Methods for treating cell proliferative disorders and viral infections
07/02/2003EP1322306A2 Use of statins (hmg-coa reductase inhibitors) for the preparation of medicament as a novel type of immunomodulator, immunosuppressor and anti-inflammatory agent
07/02/2003EP1322305A1 Use of r-arylpropionic acids for producing medicaments for treating illnesses with a rheumatic nature
07/02/2003EP1322304A1 Manipulation of oxidative phosphorylation for hypersensitizing tumor cells to glycolytic inhibitors
07/02/2003EP1322303A1 Delivery system for multi-pharmaceutical active materials at various release rates
07/02/2003EP1322301A1 Combination particles for the treatment of asthma
07/02/2003EP1322300A1 Inhalation particles incorporating a combination of two or more active ingredients
07/02/2003EP1322299A2 Composition for the transdermal delivery of fentanyl
07/02/2003EP1322298A1 Pharmaceutical oxan preparation
07/02/2003EP1322297A2 Chrono delivery formulations and method of use thereof
07/02/2003EP1322294A2 Stabilization of solid thyroid drug formulations
07/02/2003EP1322293A1 Modified release formulation
07/02/2003EP1322289A1 Spray drying process and compositions of fenofibrate
07/02/2003EP1322220A2 Methods for analyzing and using data from hypertensive patients
07/02/2003EP1322182A2 Agent having prolonged stomach retention time used to produce a longlasting saturation effect, and the use thereof
07/02/2003EP1322176A1 Use of carnitine for enhancing training-induced bradycardia
07/02/2003EP1322175A2 Food supplement
07/02/2003EP1322162A1 Disinfectant agent
07/02/2003EP1322158A1 Sustained release pharmaceutical compositions containing metformin and method of its production
07/02/2003EP1322157A2 Antimicrobial compositions formulated for use in cold temperature conditions and methods of use thereof
07/02/2003EP1322156A1 Disinfectant
07/02/2003EP1242092B1 Drug combination for the treatment of headache comprising mirtazapine and paracetamol or a non-steroidal anti-inflammatory drug
07/02/2003EP1240177B1 Benzophenone alpha-d-glycopyranosides, preparation and therapeutic use
07/02/2003EP1224180B1 Substituted azoles
07/02/2003EP1218372B1 Novel heterocyclic compounds useful as reversible inhibitors of cysteine proteases
07/02/2003EP1210346B1 New active marine alkaloids
07/02/2003EP1181290B1 Polymorphs of a crystalline azabicyclo (2,2,2) octan-3-amine citrate and their pharmaceutical compositions
07/02/2003EP1175429B1 Halo derivatives of 9-deoxo-9a-aza-9a-homerythromycin a
07/02/2003EP1171444B1 Pyrido-thieno-diazepines, method for the production thereof and pharmaceutical compositions containing said pyrido-thieno-diazepines
07/02/2003EP1150666A4 Stimulating neutrophil function to treat inflammatory bowel disease
07/02/2003EP1140861B1 Novel polyhydroxypyrazine derivatives, preparation and pharmaceutical compositions containing same
07/02/2003EP1124539B1 Pharmaceutical formulation comprising omeprazole
07/02/2003EP1073694B1 Trans-xanthophyll ester concentrates of enhanced purity and methods of making same
07/02/2003EP1059921B1 Use of macrolide compounds for the treatment of acute lung injury
07/02/2003EP1045849B1 Purine derivatives having phosphodiesterase iv inhibition activity
07/02/2003EP1041966B1 Pharmaceutical compositions comprising zafirlukast
07/02/2003EP1028954B1 Substituted imidazoles useful in the treatment of inflammatory diseases
07/02/2003EP1017371B1 Controlled release of drugs delivered by sublingual or buccal administration
07/02/2003EP1016664B1 Fused thiophene compounds and medicinal use thereof
07/02/2003EP1014954B1 Transdermal therapeutic system
07/02/2003EP0991627B1 Pyrimidinone compounds, pharmaceutical compositions containing the compounds and the process for preparing the same
07/02/2003EP0990655B1 Method for drying anhydrous paroxetine hydrochloride
07/02/2003EP0975327B1 Use of 5ht3 antagonists for promoting intestinal lavage
07/02/2003EP0973780B1 Antibacterial substituted 7-acylamino -3-(methylhydrazono) methyl-cephalosporins and intermediates
07/02/2003EP0973779B1 Crystalline amine salt of cefdinir
07/02/2003EP0970067B1 (methylsulfonyl)phenyl-2-(5h)-furanones with oxygen link as cox-2 inhibitors
07/02/2003EP0954292B1 Pharmaceutical formulations with delayed drug release
07/02/2003EP0944582B1 Ketobenzamides as calpain inhibitors
07/02/2003EP0923292B1 Improved method for systemic administration of 2,4-dienoic acid-type insecticides to terrestrial mammals
1 ... 5420 5421 5422 5423 5424 5425 5426 5427 5428 5429 5430 5431 5432 5433 5434 5435 5436 5437 5438 5439 5440 ... 7860